A phase I dose escalation and pharmacokinetic trial of intra-vesical gemcitabine in the treatment of recurrent superficial transitional cell carcinoma of the bladder

By Maddineni S.   Sangar V.   King H.   Betts C.   O'Flynn K.   Lupton E.   George N.   Ramani V.   Clarke N.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 192-192

Elsevier

Access to resources Recommend Favorite

Initial report on intravesical administration of n-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder

By Greenberg R.E.   Bahnson R.R.   Wood D.   Childs S.J.   Bellingham C.   Edson M.   Bamberger M.H.   Steinberg G.D.   Israel M.   Sweatman T.   Giantonio B.   O'Dwyer P.J.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 471-475

Elsevier

Access to resources Recommend Favorite

Intravesical bacillus Calmette-Guerin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder - 15 years outcome

By Baniel J.   Grauss D.   Engelstein D.   Sella A.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 785-789

Elsevier

Access to resources Recommend Favorite

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder

By Serretta V.   Piazza S.   Pavone C.   Piazza B.   Pavone-Macaluso M.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 647-651

Elsevier

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K.   Schultz M.   Stout P.   Fan K.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite